Healthcare Regulation (HIPAA)

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

A new report reveals which cannabis brands dominate AI search, just as federal rescheduling creates chaos and opportunity. But with AI often refusing to answer, who wins?

EnableComp is pulling back the curtain on enterprise AI, detailing a production model that boosts development 5-7x while navigating healthcare's tough regulations.

A new partnership is bringing enterprise voice AI to the Medicare front lines, promising to ease a system strained by high call volumes and complex rules.

Glass House Brands follows a new playbook, splitting its business to chase a NYSE listing. Is this the key that unlocks institutional capital for the entire sector?

Gene therapy firm uniQure plans a 2026 FDA submission for AMT-130, a potential first disease-modifying treatment for Huntington's, on an accelerated track.

Choosing the wrong regulatory partner can derail a market launch. A new guide from Q&C Services offers a veteran's roadmap for de-risking expansion.

New appointments bring deep legal and pharma expertise to Canada's Patented Medicine Prices Review Board, signaling a pivotal moment under new 2026 guidelines.

A new bill named for a man failed by the system aims to modernize medical psilocybin access. But can it overcome bureaucratic inertia and position Canada as a leader?

A new partnership between HCPro and ZHealth aims to solve the costly, error-prone challenge of specialty coding in radiology and cardiology. Here’s why.

When a long-term disability claim is denied, the clock starts ticking. Here’s how to understand the insurer's playbook and the legal maze you must navigate.

Canada's sweeping new bail and sentencing law promises safer streets, but critics warn it could strain the justice system and erode fundamental rights.

As Colorado's special education needs grow, private schools like The ACES report success. But what does this model reveal about the broader system?

With the EU's Cyber Resilience Act's 24-hour reporting deadline looming, a new class of AI-powered platforms is emerging to manage this unprecedented compliance risk.

Beyond a simple rebrand, CTM's new integrations and strategic hires reveal a deeper play to solve the market's biggest data disconnect for modern business.

A new partnership between IS3WARE and Privacy Horizon signals a pivotal shift in how our most sensitive sectors will defend against digital and regulatory threats.

A new Supreme Court ruling just upended risk for freight brokers. RoxStart AI's new platform offers a timely, tech-driven defense for the industry's backbone.

A guidance cut at Sanuwave reveals a deeper crisis in wound care, driven by CMS policy shifts that are fueling a disruptive secondary equipment market.

A new patent gives Cognition Therapeutics’ lead drug candidate protection until 2045. Here’s why this strategic move is about more than just IP.

A new AI platform promises to slash drug development red tape. But can it overcome the industry’s deep-rooted challenges of privacy, trust, and integration?